Cancer stem cell niche: the place to be

T Borovski, F De Sousa E Melo, L Vermeulen… - Cancer research, 2011 - AACR
T Borovski, F De Sousa E Melo, L Vermeulen, JP Medema
Cancer research, 2011AACR
Tumors are being increasingly perceived as abnormal organs that, in many respects,
recapitulate the outgrowth and differentiation patterns of normal tissues. In line with this idea
is the observation that only a small fraction of tumor cells is capable of initiating a new tumor.
Because of the features that these cells share with somatic stem cells, they have been
termed cancer stem cells (CSC). Normal stem cells reside in a “stem cell niche” that
maintains them in a stem-like state. Recent data suggest that CSCs also rely on a similar …
Abstract
Tumors are being increasingly perceived as abnormal organs that, in many respects, recapitulate the outgrowth and differentiation patterns of normal tissues. In line with this idea is the observation that only a small fraction of tumor cells is capable of initiating a new tumor. Because of the features that these cells share with somatic stem cells, they have been termed cancer stem cells (CSC). Normal stem cells reside in a “stem cell niche” that maintains them in a stem-like state. Recent data suggest that CSCs also rely on a similar niche, dubbed the “CSC niche,” which controls their self-renewal and differentiation. Moreover, CSCs can be generated by the microenvironment through induction of CSC features in more differentiated tumor cells. In addition to a role in CSC maintenance, the microenvironment is hypothesized to be involved in metastasis by induction of the epithelial-mesenchymal transition, leading to dissemination and invasion of tumor cells. The localization of secondary tumors also seems to be orchestrated by the microenvironment, which is suggested to form a premetastatic niche. Thus, the microenvironment seems to be of crucial importance for primary tumor growth as well as metastasis formation. Combined with its role in the protection of CSCs against genotoxic insults, these data strongly put forward the niche as an important target for novel therapies. Cancer Res; 71(3); 634–9. ©2011 AACR.
AACR